A weak appointment can delay registration, consume management time and leave a brand inactive while exclusivity prevents better options. These seven mistakes recur across medical and dental market entry in MENA.

1. Treating MENA as one market

Countries differ substantially. A strong UAE distributor may have no effective route into Saudi Arabia or Egypt. Define priorities and appoint according to local capability rather than assuming one partner can cover the entire region.

2. Choosing the biggest name automatically

Scale brings resources, but also many competing priorities. Evaluate how much attention the team will allocate, who owns the brand internally and whether the product fits the distributor’s growth strategy.

3. Relying on exhibition interest

Exhibitions are valuable for visibility and introductions. They do not replace qualification. Follow up directly, verify decision authority, request evidence and assess whether interest becomes a credible plan.

4. Ignoring competing brands

A distributor may carry an apparently complementary portfolio while an internal product competes for the same customers, budget or sales-team attention. Map the complete portfolio and ask how your positioning will remain distinct.

5. Granting exclusivity without milestones

Exclusivity can motivate investment, but unconditional exclusivity can also immobilize a market. Connect it to time-bound registration progress, initial orders, agreed activity, reporting and performance reviews, with appropriate legal advice.

6. Discussing registration separately from growth

Registration determines timing, responsibilities and sometimes long-term control. The regulatory plan should be aligned with the commercial plan, including ownership of documents, costs, termination scenarios and launch preparation.

7. Disappearing after appointment

Even a capable distributor needs product knowledge, responsive manufacturer support, training, KOL development, marketing assets and regular management follow-up. Sustainable growth is built after signing.

A better approach

Define the partner profile, map the market, approach decision-makers, compare evidence, align commercial and regulatory responsibilities, set measurable expectations and maintain a regular development rhythm. Distributor selection is not a search for names; it is a risk-managed market-development process.

Planning a new distributor appointment?

Gazika supports international healthcare manufacturers from market mapping and qualification through appointment, launch and distributor performance.

Book a focused consultation